Skip to main content
RLMD logo

RLMD · Relmada Therapeutics, Inc. · Investor Relations

Track RLMD — free
$2.91 +0.05 (+1.75%) Play latest call Q3 2026 earnings call transcript
Market Cap
$304.61M
Shares
106.69M
Volume · Nov 19 280.3K Avg daily vol (3M) 1.41M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-11-16 Relmada Therapeutics Appoints Uro-Oncology Leader Jørn Skibsted Jakobsen, MD, PhD, as Chief Development Officer
2026-11-12 Relmada Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
2026-11-04 Relmada Therapeutics to Participate at the Jefferies Global Healthcare Conference in London
2026-11-03 Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026
2026-08-06 Relmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
2026-07-28 Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer
2026-05-12 Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
2026-03-20 Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
2026-03-09 Relmada Therapeutics Announces Oversubscribed $160.0 Million Private Placement Financing
2026-03-09 Relmada Therapeutics Reports 12-Month Phase 2 Interim Data for NDV-01 in Non-Muscle Invasive Bladder Cancer
2025-11-13 Relmada Therapeutics Reports Third Quarter 2025 Financial Results and Provides Key Clinical, Regulatory, and Corporate Updates
2025-11-05 Relmada Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
2025-11-04 Relmada Announces FDA Feedback Supporting 2 Separate Acceptable Registrational Study Paths for NDV-01 in Non-muscle Invasive Bladder Cancer Announces NDV-01 9-Month Follow-up Safety and Efficacy Data in NMIBC

Past events

Date Event Type
2026-11-16 Jefferies Global Healthcare Conference in London Conference
2026-11-12 Third Quarter 2026 Earnings Call Earnings call
2026-08-06 Q2 2026 Financial Results Conference Call Earnings call
2026-07-04 Jefferies Global Healthcare Conference Conference
2026-06-04 Jefferies Global Healthcare Conference Conference
2026-05-27 2026 Annual Meeting of Stockholders Shareholder meeting
2026-05-18 American Urology Association (AUA2026) Event
2026-05-15 American Urology Association (AUA2026) Event
2026-05-12 Earnings conference call (announced in 8-K) Earnings call
2026-03-19 Q4 Earnings conference call (announced in 8-K) Earnings call
2026-03-10 Leerink Partners Global Healthcare Conference Conference
2025-12-04 Society of Urologic Oncology 26th Annual Meeting Shareholder meeting
2025-11-13 Q3 2025 Financial Results Conference Call Earnings call
2025-08-07 Q2 2025 Financial Results Conference Call Earnings call

Source: https://ir.relmada.com/

Key facts CIK 1553643 CUSIP 75955J402 13F (30d) 150 filings 132 filers Visit website Investor relations